Fortis Healthcare Ltd.

NSE: FORTIS · Healthcare

₹766.90-6.45%06 Nov 2026

Ask the data

Instant answers about Fortis Healthcare Ltd. — computed from its filings, no language model

Market cap₹57,898 cr

Current price₹766.90

High / Low₹1,045 / ₹713

P/E55.8

P/B5.53

Book value₹138.8

ROE9.9%

ROCE12.4%

Debt / equity0.30

Dividend yield0.13%

EPS (TTM)₹13.75

Face value₹10

Price & valuation

split & bonus adjusted · pick a metric and range

Annual performance

annual · ₹ crore · line = operating margin

showing latest 6 of 9 periods

	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	FY26
Revenue	4,561	4,469	4,632	4,030	5,718	6,298	6,893	7,783	9,128
EBITDA	273	225	610	404	1,069	1,101	1,268	1,588	2,085
Operating margin	6.0%	5.0%	13.2%	10.0%	18.7%	17.5%	18.4%	20.4%	22.8%
Interest	258	337	205	166	147	129	131	184	314
Depreciation	239	233	292	291	301	316	342	386	449
Profit before tax	-965	-475	227	-4	964	792	848	996	1,350
Tax	23	114	148	99	198	181	213	198	302
Net profit	-1,009	-224	136	-110	555	589	599	774	1,042
EPS ₹	-19.46	-3.70	0.77	-1.45	7.35	7.80	7.93	10.26	13.80
Operating cash flow	—	—	—	—	865	822	1,100	1,424	1,602
Capex	—	—	—	—	215	447	942	847	946
Dividend paid	—	—	—	—	0	16	86	109	78
Total assets	8,622	11,951	11,348	11,155	11,885	12,434	13,289	13,692	15,966
Equity	4,062	6,601	6,661	6,120	6,178	7,242	7,663	8,917	9,896

Quarterly performance

last 35 quarters · ₹ crore

showing latest 8 of 35 periods

	MAR '18	JUN '18	SEP '18	DEC '18	MAR '19	JUN '19	SEP '19	DEC '19	MAR '20	JUN '20	SEP '20	DEC '20	MAR '21	JUN '21	SEP '21	DEC '21	MAR '22	JUN '22	SEP '22	DEC '22	MAR '23	JUN '23	SEP '23	DEC '23	MAR '24	JUN '24	SEP '24	DEC '24	MAR '25	JUN '25	SEP '25	DEC '25	MAR '26	JUN '26	SEP '26
Revenue	1,086	1,042	1,140	1,103	1,184	1,138	1,212	1,169	1,113	606	995	1,177	1,252	1,410	1,463	1,467	1,378	1,488	1,607	1,560	1,643	1,657	1,770	1,680	1,786	1,859	1,988	1,928	2,007	2,167	2,331	2,265	2,365	2,545	2,735
Operating profit	13	8	64	38	115	142	184	157	126	-103	120	190	197	275	284	287	221	251	303	276	271	272	330	284	381	343	435	375	435	491	556	506	532	537	623
Operating margin	1.2%	0.8%	5.6%	3.4%	9.7%	12.5%	15.2%	13.4%	11.3%	-17.0%	12.1%	16.2%	15.8%	19.5%	19.4%	19.6%	16.1%	16.9%	18.8%	17.7%	16.5%	16.4%	18.7%	16.9%	21.3%	18.4%	21.9%	19.5%	21.7%	22.6%	23.9%	22.3%	22.5%	21.1%	22.8%
Other income	19	29	11	43	10	20	10	5	18	4	26	10	6	8	8	7	6	21	16	12	14	8	14	7	10	13	13	21	20	15	23	8	4	14	7
Interest	64	76	85	111	65	51	49	48	57	41	42	42	41	38	40	38	30	31	33	33	32	31	32	33	35	35	36	45	68	70	75	86	84	80	78
Depreciation	60	57	56	60	60	71	71	70	80	72	74	73	72	73	75	76	77	74	77	83	82	79	84	87	92	91	95	97	102	101	106	120	122	122	128
Profit before tax	-927	-96	-162	-218	0	49	127	44	7	-211	30	85	92	478	178	188	120	166	260	183	182	171	231	179	267	229	257	277	232	348	422	262	318	359	426
Tax	-9	-34	-15	-20	183	-26	6	117	50	-20	23	49	48	56	51	51	39	42	50	44	45	47	49	49	68	56	68	25	49	84	97	68	53	90	112
Net profit	-932	-71	-167	-197	151	68	111	-76	-45	-179	-4	30	43	264	107	117	68	122	204	130	133	112	174	135	179	166	176	248	184	260	322	194	266	266	312
EPS ₹	-17.97	-1.36	-3.21	-3.06	1.78	0.90	1.47	-1.01	-0.59	-2.37	-0.05	0.40	0.57	3.49	1.42	1.55	0.90	1.62	2.71	1.72	1.76	1.48	2.30	1.78	2.37	2.20	2.34	3.28	2.44	3.45	4.26	2.57	3.52	3.53	4.14
Revenue YoY	—	—	—	—	9.0%	9.2%	6.3%	6.0%	-6.0%	-46.8%	-17.9%	0.7%	12.5%	132.7%	47.0%	24.6%	10.0%	5.5%	9.9%	6.4%	19.2%	11.4%	10.1%	7.7%	8.7%	12.2%	12.3%	14.8%	12.4%	16.6%	17.3%	17.5%	17.8%	17.5%	17.3%
Profit YoY	—	—	—	—	—	—	—	—	-129.4%	-363.9%	-103.5%	—	—	—	—	290.4%	57.4%	-53.6%	91.3%	11.0%	95.0%	-8.6%	-15.0%	3.9%	34.8%	48.3%	1.2%	84.1%	2.9%	57.0%	83.1%	-21.9%	44.6%	2.3%	-3.0%

Earlier results (standalone, Sep '07 – Dec '17)

₹ crore · from BSE, before the NSE XBRL filings begin

Fortis Healthcare Ltd. reports consolidated figures above. Quarterly consolidated results only became mandatory in India in 2019, so the earlier history available is the standalone company only (excluding subsidiaries). It is shown separately so the two bases are never mixed.

Full years

showing latest 8 of 9 periods

	FY09†	FY10†	FY11†	FY12†	FY13†	FY14†	FY15†	FY16†	FY17†
Revenue	174	210	258	280	353	369	611	612	645
Operating profit	8	22	23	3	1	-89	-153	-118	-147
Operating margin	4.5%	10.5%	9.0%	1.2%	0.2%	-24.0%	-25.1%	-19.3%	-22.7%
Other income	19	41	182	128	191	238	223	147	169
Interest	22	22	54	103	134	91	81	62	106
Depreciation	12	11	10	12	23	17	—	25	27
Profit before tax	-7	30	142	201	32	41	-36	-74	-114
Tax	0	0	0	0	15	17	-2	0	-39
Net profit	-7	30	142	201	17	24	-34	-74	-75

Quarters

showing latest 8 of 42 periods

	SEP '07†	DEC '07†	MAR '08†	JUN '08†	SEP '08†	DEC '08†	MAR '09†	JUN '09†	SEP '09†	DEC '09†	MAR '10†	JUN '10†	SEP '10†	DEC '10†	MAR '11†	JUN '11†	SEP '11†	DEC '11†	MAR '12†	JUN '12†	SEP '12†	DEC '12†	MAR '13†	JUN '13†	SEP '13†	DEC '13†	MAR '14†	JUN '14†	SEP '14†	DEC '14†	MAR '15†	JUN '15†	SEP '15†	DEC '15†	MAR '16†	JUN '16†	SEP '16†	DEC '16†	MAR '17†	JUN '17†	SEP '17†	DEC '17†
Revenue	41	39	41	40	42	46	46	51	50	52	58	62	65	65	66	68	72	68	72	85	87	89	92	98	89	88	94	151	158	148	154	154	153	150	154	166	169	158	152	168	170	166
Operating profit	-1	2	4	2	-0	3	3	4	6	5	7	9	5	7	3	-3	-6	12	1	2	-0	-5	3	-11	-20	-16	-41	-41	-34	-41	-37	-38	-30	-27	-23	-21	-15	-83	-27	-14	-7	-11
Operating margin	-1.7%	5.8%	9.0%	5.6%	-0.6%	6.6%	6.0%	8.7%	11.5%	10.5%	11.3%	14.7%	7.4%	10.6%	3.9%	-4.3%	-8.8%	17.4%	1.0%	2.6%	-0.2%	-5.1%	3.3%	-11.1%	-22.7%	-18.4%	-43.7%	-27.4%	-21.5%	-28.0%	-23.8%	-24.7%	-19.8%	-17.8%	-14.8%	-12.9%	-8.7%	-52.9%	-17.7%	-8.2%	-4.1%	-6.6%
Other income	6	11	11	4	7	4	4	4	4	12	21	43	55	45	39	27	13	54	34	53	51	49	38	47	66	73	53	56	56	55	55	42	34	33	39	47	39	42	41	38	35	32
Interest	8	9	2	5	6	6	5	7	5	3	8	21	19	7	6	9	25	37	31	33	32	33	37	22	27	21	21	21	21	21	19	15	11	15	22	26	28	31	21	18	16	13
Depreciation	3	3	3	3	3	3	3	3	3	3	3	3	3	3	2	3	3	3	3	4	4	4	12	4	4	5	4	—	7	5	6	6	6	6	8	6	6	7	8	7	7	7
Profit before tax	-5	2	10	-1	-3	-2	-1	-1	2	12	17	28	38	43	34	12	-21	26	185	18	15	6	-7	9	14	31	-13	-12	-5	-12	-7	-17	-26	-17	-14	-7	-11	-81	-15	-1	4	0
Tax	0	0	0	0	0	0	0	0	-0	0	0	0	0	0	0	0	0	0	0	5	6	3	2	1	5	12	-1	0	0	-2	0	0	0	0	0	0	-7	-19	-13	0	2	1
Net profit	-5	2	10	-1	-3	-2	-1	-2	2	12	17	28	38	43	34	12	-21	26	185	13	9	4	-9	8	10	19	-12	-12	-5	-10	-7	-17	-26	-17	-14	-7	-5	-61	-2	-1	2	-1
EPS ₹	-0.93	0.28	1.70	-0.26	-0.58	-0.28	-0.03	-0.07	0.10	-0.50	0.64	0.85	1.03	1.13	0.88	0.29	-0.53	0.64	4.57	0.33	0.23	0.13	-0.22	0.18	0.21	0.41	-0.26	-0.32	-0.11	-0.21	-0.15	-0.36	-0.56	-0.36	-0.30	-0.15	-0.10	-1.32	-0.03	-0.02	0.03	-0.02
Revenue YoY	—	—	—	—	3.4%	19.3%	13.3%	25.6%	18.6%	12.3%	25.1%	21.7%	30.6%	26.6%	14.7%	10.8%	10.1%	3.6%	8.6%	24.5%	21.3%	31.8%	27.6%	15.6%	2.1%	-1.7%	2.6%	54.0%	77.9%	68.4%	63.3%	2.0%	-3.0%	1.9%	-0.2%	7.7%	10.8%	4.8%	-1.3%	1.4%	0.5%	5.4%
Profit YoY	—	—	—	—	—	-201.9%	-108.2%	—	—	—	—	—	1550.0%	244.6%	98.5%	-57.5%	-156.6%	-39.3%	447.0%	13.5%	—	-86.1%	-104.9%	-43.4%	1.5%	418.3%	—	-261.3%	-153.5%	-153.3%	—	—	—	—	—	—	—	—	—	—	—	—

Returns & margins

trailing-twelve-month, per quarter

showing latest 8 of 32 periods

	DEC '18	MAR '19	JUN '19	SEP '19	DEC '19	MAR '20	JUN '20	SEP '20	DEC '20	MAR '21	JUN '21	SEP '21	DEC '21	MAR '22	JUN '22	SEP '22	DEC '22	MAR '23	JUN '23	SEP '23	DEC '23	MAR '24	JUN '24	SEP '24	DEC '24	MAR '25	JUN '25	SEP '25	DEC '25	MAR '26	JUN '26	SEP '26
ROE	-33.6%	-4.3%	-2.2%	2.0%	3.8%	0.9%	-2.8%	-4.6%	-3.0%	-1.8%	5.4%	7.2%	8.7%	9.0%	6.7%	7.4%	7.5%	8.1%	8.0%	7.2%	7.3%	7.8%	8.5%	8.3%	9.8%	8.7%	9.7%	10.5%	9.9%	10.5%	10.6%	9.9%
ROCE	-19.5%	-1.6%	-0.2%	2.8%	5.1%	5.4%	2.0%	0.7%	1.2%	2.2%	11.5%	13.5%	14.8%	15.5%	11.1%	10.6%	10.5%	11.3%	11.3%	10.4%	10.3%	11.5%	12.2%	11.9%	13.1%	10.4%	11.7%	11.9%	12.1%	13.0%	13.2%	12.4%
Net margin	-31.3%	-6.3%	-3.2%	2.9%	5.4%	1.3%	-4.6%	-7.8%	-5.1%	-2.7%	6.9%	8.4%	9.5%	9.7%	7.1%	8.6%	8.7%	9.3%	8.9%	8.3%	8.2%	8.7%	9.2%	9.0%	10.2%	9.9%	10.7%	12.0%	10.9%	11.4%	11.0%	10.5%
EBITDA margin	2.8%	5.0%	7.9%	10.3%	12.7%	13.2%	8.9%	7.7%	8.6%	10.0%	16.2%	17.9%	18.7%	18.7%	18.0%	17.9%	17.4%	17.5%	17.4%	17.3%	17.1%	18.4%	18.9%	19.7%	20.3%	20.4%	21.5%	22.0%	22.7%	22.8%	22.4%	22.2%
Debt / equity	0.34	0.28	0.28	0.28	0.28	0.20	0.20	0.20	0.20	0.21	0.21	0.21	0.21	0.16	0.16	0.18	0.18	0.13	0.13	0.14	0.14	0.11	0.11	0.15	0.15	0.28	0.28	0.33	0.33	0.29	0.29	0.30
Interest coverage	-3.17	-0.41	-0.06	0.85	2.04	2.11	0.83	0.31	0.51	0.97	5.19	6.16	6.94	7.56	5.67	6.56	6.73	7.13	7.16	6.98	6.96	7.48	7.73	7.69	7.80	6.40	6.09	5.97	5.24	5.29	5.18	5.15
Asset turnover	0.51	0.37	0.38	0.39	0.39	0.41	0.36	0.34	0.34	0.36	0.43	0.48	0.50	0.48	0.49	0.48	0.49	0.51	0.52	0.52	0.53	0.52	0.53	0.54	0.56	0.57	0.59	0.56	0.58	0.57	0.60	0.60

Balance sheet

equity vs borrowings over time · ₹ crore

showing latest 6 of 18 periods

	MAR '14‡	MAR '15‡	MAR '16‡	MAR '17‡	MAR '18‡	MAR '19‡	MAR '20‡	MAR '21‡	MAR '22‡	SEP '22	MAR '23	SEP '23	MAR '24	SEP '24	MAR '25	SEP '25	MAR '26	SEP '26
Share capital	463	463	463	518	519	755	755	755	755	755	755	755	755	755	755	755	755	755
Other equity / reserves	3,680	3,432	3,998	4,626	3,543	5,846	5,906	5,365	5,423	6,193	6,487	6,855	6,908	7,092	8,162	8,938	9,141	9,723
Total equity	4,143	3,895	4,461	5,143	4,062	6,601	6,661	6,120	6,178	6,948	7,242	7,610	7,663	7,847	8,917	9,693	9,896	10,478
Borrowings	1,691	1,031	1,378	1,959	1,400	1,868	1,317	1,271	966	1,231	926	1,033	858	1,186	2,475	3,195	2,873	3,164
Current liabilities	—	—	1,450	1,926	2,134	3,591	2,579	1,233	1,269	1,321	1,314	2,914	3,170	3,380	1,607	1,722	2,121	2,397
Non-current liabilities	—	—	929	1,480	1,171	1,248	1,563	3,204	3,607	3,168	2,907	1,391	1,562	1,484	2,915	3,597	3,676	3,255
Total assets	7,881	7,616	7,232	9,717	8,622	11,951	11,348	11,155	11,885	12,278	12,434	12,785	13,289	13,597	13,692	15,013	15,966	16,415
Property, plant & equipment	1,794	1,743	1,426	2,974	2,849	4,694	3,922	3,910	3,832	4,968	4,850	5,039	5,268	5,578	5,848	6,599	5,348	7,020
Capital work-in-progress	142	224	203	235	194	421	189	163	193	237	228	525	540	435	404	306	432	495
Investments	—	—	—	—	—	—	175	186	104	151	210	214	230	175	169	220	243	254
Inventories	62	64	60	62	67	57	78	77	123	120	123	123	107	115	115	127	135	153
Receivables	441	409	464	484	470	542	459	458	512	627	582	693	628	793	784	1,017	1,044	1,323
Cash & equivalents	259	190	142	544	130	794	182	261	143	127	141	90	235	266	140	101	407	150

Cash flow

annual · ₹ crore · line = free cash flow

showing latest 5 of 13 periods

	FY14‡	FY15‡	FY16‡	FY17‡	FY18‡	FY19‡	FY20‡	FY21‡	FY22	FY23	FY24	FY25	FY26
Cash from operations	479	24	195	966	493	-179	172	485	865	822	1,100	1,424	1,602
Cash from investing	2,669	213	113	-1,002	-335	-3,323	60	-135	-514	-374	-886	-779	-1,538
Cash from financing	-3,217	-304	-354	259	-672	4,257	-862	-143	-517	-471	-86	-714	164
Capex	600	—	230	278	180	83	156	219	215	447	942	847	946
Free cash flow	-121	—	-35	689	313	-262	16	267	650	375	158	577	656
Dividends paid	—	—	—	—	—	—	—	—	0	16	86	109	78

Where the assets sit

Sep '26 · ₹ crore

Fixed assets (PPE)

₹7,020 cr43%

CWIP

₹495 cr3%

Investments

₹254 cr2%

Inventories

₹153 cr1%

Receivables

₹1,323 cr8%

Cash & equivalents

₹150 cr1%

Other assets

₹7,020 cr43%

Peer comparison

largest in Healthcare · this company in bold

Company	Market cap ₹cr	Price	P/E	P/B	ROE
Sun Pharmaceutical Industries Ltd.	4,46,270	1,860.00	40.7	5.00	12.3%
Divi's Laboratories Ltd.	2,73,493	10,320.50	93.5	16.32	17.5%
Torrent Pharmaceuticals Ltd.	1,80,671	4,750.00	85.1	9.83	11.6%
Laurus Labs Ltd.	1,26,430	2,340.00	94.4	20.86	22.1%
Apollo Hospitals Enterprise Ltd.	1,21,453	8,446.00	54.2	11.45	21.1%
Zydus Lifesciences Ltd.	1,19,550	1,197.90	28.6	4.30	15.0%
Dr. Reddy's Laboratories Ltd.	1,14,646	1,373.00	40.9	2.95	7.2%
Cipla Ltd.	1,13,988	1,411.00	39.3	3.22	8.2%
Mankind Pharma Ltd.	1,04,902	2,540.00	46.7	5.97	12.8%
Aurobindo Pharma Ltd.	1,03,572	1,800.00	26.0	2.63	10.1%
Fortis Healthcare Ltd.	57,898	766.90	55.8	5.53	9.9%

StoxGud checklist: Neutral setup · 4/10

Price above 50-day average
Price above 200-day average
50-day average above 200-day (uptrend)
RSI in healthy 40–70 zone
Positive 1-year return
Return on equity above 15%
Debt to equity below 1
Revenue growing year on year
Net profit margin above 10%
P/E below industry median

A rules-based screen of trend, momentum, quality and valuation. Educational only — not a buy or sell recommendation.

Returns & technicals

1 month-1.6%

6 months-19.1%

1 year-27.3%

3Y CAGR+32.0%

5Y CAGR+25.0%

10Y CAGR+16.3%

50-day avg₹823.11

200-day avg₹893.32

RSI (14)57

Long-term financials (FY15–FY16)

from published annual reports

Year	Revenue	Profit before tax	Net profit
FY16	₹4,265 Cr	—	₹21 Cr
FY15	₹3,966 Cr	—	₹14 Cr

Years before FY17 follow the older Indian GAAP standard, so they are not exactly comparable with recent years.

Compare Fortis Healthcare Ltd. with

Alkem Laboratories vs Fortis Healthcare Biocon vs Fortis Healthcare Fortis Healthcare vs Abbott India Fortis Healthcare vs Gland Pharma Fortis Healthcare vs Anthem Biosciences

FAQs

What is the share price of Fortis Healthcare Ltd.?

Fortis Healthcare Ltd. (FORTIS) closed at ₹766.90 on NSE on 06 Nov 2026.

What is the market cap of Fortis Healthcare Ltd.?

₹57,898 crore at the latest close.

What is the P/E ratio of Fortis Healthcare Ltd.?

55.8, on trailing-twelve-month earnings from its filings.

How fast is Fortis Healthcare Ltd. growing?

Fortis Healthcare Ltd.: revenue has compounded at 13.2% a year over three years; net profit at 21.0% a year. Latest-quarter revenue is up 17.3% year on year, profit down 3.0%.

How profitable is Fortis Healthcare Ltd.?

On a trailing-twelve-month basis return on equity is 9.9%, return on capital employed 12.4%, operating margin 22.2%, net margin 10.5%.

How much debt does Fortis Healthcare Ltd. have?

Fortis Healthcare Ltd. is lightly geared: debt to equity is 0.30 with borrowings of ₹3,164 cr against cash of ₹150 cr (balance sheet of 2026-09-30). Operating profit covers interest 5.2 times.

Financials parsed from Fortis Healthcare Ltd.'s own XBRL filings to NSE (consolidated), ₹ crore unless marked. Quarterly from MAR '18, annual from FY18, balance sheet from Mar '14. * = derived (full year or half year minus earlier quarters). ‡ = balance sheet / cash flow read from the company's published annual report (same basis), for years before the NSE filings carry them; each one checked to add up. Information only, not investment advice.